The Council in partnership with Nashville Capital Network presents
Developing Health Care Ventures: Investor and Entrepreneur Collaborations
Annie Lamont is a Co-Founder and Managing Partner of Oak HC/FT where she focuses on growth equity and early-stage venture opportunities in Healthcare and FinTech. Lamont currently serves on the Boards of Advise Health Holdings, Brightline, CareBridge, Clearco, Main Street Health, Oncology Analytics, Quartet, Truepill, Vesta Health, VillageMD and is a Board Observer at Notable. Lamont is also actively involved with Blend, Devoted Health, Inscripta, Komodo Health, Precision Medicine Group, and Rubicon Founders. Lamont has appeared on the Forbes Midas List, Institutional Investor’s FinTech Finance 40 list, and the Top 100VentureCapitalist rankings published by CB Insights and The New York Times. She was the first recipient of the National Venture Capital Association’s award for Excellence in Healthcare Innovation. Lamont was also honored with Healthcare Private Equity Association’s 2017 Russell L. Carson Award for lifetime achievement in health care investing. Lamont serves as a core participant of the Health and Human Services Deputy Secretary’s Innovation and Investment Summit. See here for a list of Lamont’s previous investments.
Ben R. Leedle, Jr., is a transformative business leader who envisions and creates worldclass companies. He has spent his career building and delivering value-based businesses established and grown on the fundamental proposition that healthier people cost less and perform better. He is broadly recognized as the visionary and driving force behind transforming Healthways, Inc. from a small company focused on diabetes treatment to the number one independent population health management and well-being improvement company in the world. Among his collaborative accomplishments during his tenure as CEO, Leedle co-founded both, the Blue Zones Project and the Gallup-Healthways Well-Being Index innovations for transformation. Leedle is currently leading a new division of Adventist Health focused on building a portfolio of solutions to improve the well-being of consumers, organizations and whole communities across the more than 75 primary and secondary service areas of the health system. Concurrently, he is also the President & CEO of Blue Zones, now a subsidiary of Adventist Health. In addition to servicing the footprint of Adventist Health, Blue Zones serves over 50 communities composed of city, county, regional and state level initiatives nationally.
G.B. Pratt has a passion for health care innovation and delivering services that exceed expectations. With a history of GI issues and a desire to help patients take control of their health, he started ModifyHealth in 2018 to bring relief to those suffering from chronic conditions where dietary modification is a recommended treatment. ModifyHealth is on a mission to change lives by making food as medicine simple and sustainable. Prior to ModifyHealth, Pratt helped launch EndoChoice, a developer of innovative health care products and services for the GI space. EndoChoice grew from a startup in 2008 to public offering in 2015 and final sale to Boston Scientific in 2016. Pratt has served in a variety of management positions for health care organizations. He was the co-founder and CEO of VLink, an integration platform that was ultimately sold to Portico Systems, a partner company of Safeguard Scientifics. From 2002 to 2006 he held several roles, including Vice President of Sales for Eko Systems, a provider of hospital-based EMR’s for the perioperative space.
Brad Smith is the Founder and Chief Executive Officer of Russell Street Ventures, an innovative health care firm focused on launching and scaling companies that serve some of our nation’s most vulnerable patient populations. Smith also serves as the Chief Executive Officer of Main Street Health, RSV’s latest venture. Main Street Health is a value-based health care company focused exclusively on serving rural America. Smith was the Co-Founder and Chief Executive Officer of Aspire Health, which he grew into the nation’s largest home-based palliative care provider before selling it to Anthem in 2018.
A senior partner at Bass, Berry & Sims, Leigh Walton has advised a wide variety of public companies in the areas of corporate governance, mergers and acquisitions, private equity transactions, and securities offerings. She led the regulatory team for the nation’s leading health care provider through the largest domestic leveraged buyout in history at the time. Walton has been instrumental in developing the national health care practice at Bass, Berry & Sims. She is known for her ability to blend mergers and acquisitions, securities, and health care law in providing practical advice to a broad range of providers. Walton is past Chair of the ABA Business Law Section Mergers & Acquisitions Committee, which has more than 4,000 members in 40 countries on five continents. She is an Adjunct Professor at Vanderbilt University Law School and a frequent presenter at national health law programs as well as securities regulation and corporate governance seminars.
Welcome, New Council Members